This Project Grant award of $432,326 from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) supports the Translational Cancer Biology (TCB) T32 Training Program at the University of Texas Southwestern Medical Center. The program aims to train pre-doctoral and post-doctoral scientists in conducting independent cancer research, fostering their intellectual, technical, and communication skills for success in academic or industry settings. The award provides funding...
This federal Project Grant award for $166,428 from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) will support a new T32 predoctoral training program at Stanford University to prepare the next generation of multi-disciplinary cancer researchers. The program, titled "Genetic and Environmental Basis of Cancer Risk and Disparities (GECARD)," will provide integrative training across fields like epidemiology, biostatistics, genetics, environmental health, and...
This federal Project Grant award, ID T32CA285265, was provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program. The $178,541 award will fund the "Experimental Therapeutics in Cancer (ETC) Training Program" at Oregon Health & Science University (OHSU), an NCI-designated Comprehensive Cancer Center. The ETC Training Program will provide a 2-year postdoctoral training program to 9 PhD and MD scientists focused on translating scientific...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $358,528 Project Grant under the Cancer Research Manpower (CFDA 93.398) program by the National Cancer Institute, a component of the National Institutes of Health. The 5-year grant, effective September 1, 2024, will support the EPIGENETICS, DNA REPAIR AND GENOMICS (EDGE) TRAINING PROGRAM IN CANCER. This program will provide cross-disciplinary training to 4 predoctoral students per year in the areas of cancer...
This Project Grant award of $315,143.00 from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) supports clinical trial research in the oncology landscape. The award, which has an ultimate completion date of August 31, 2029, is being provided to The Ohio State University, a leading public research university. Through this funding, The Ohio State University will conduct innovative cancer research focused on understanding cancer mechanisms, developing new diagnostic and...
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $140,097 to The University of Texas Southwestern Medical Center to develop data-driven mechanistic models for understanding how cell morphology controls oncogenic signaling pathways implicated in cancer cell survival and proliferation. The 2-year project aims to integrate experimental and computational approaches to quantify the relationship between constrained cell geometries, such as...
The National Cancer Institute awarded a $118,687 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the University of Florida to support the "STRONGER" program. This 5-year program (6/24/2025 - 5/31/2030) will provide 8 undergraduate students annually from non-R1 universities, including Historically Black Colleges and Universities and Hispanic-Serving Institutions, with hands-on cancer research internships. The interns will be paired with graduate student mentors...
The National Cancer Institute (NCI) awarded Emory University a $312,737 Project Grant under the Cancer Research Manpower (CFDA 93.398) federal grant program. The "Georgia Science Education Initiative NCI YES (GA-YES)" program aims to recruit and train high school students underrepresented in STEM careers, with a focus on rural and lower socioeconomic status students, in cancer research and disparities. Key program components include: 1) a summer mentored cancer research training...
This $434,379 Project Grant awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports research to characterize the impact of known cancer predisposition mutations and develop models for cancer misdiagnosis using data from the All of Us Research Program. The award will be used by Brigham Young University (BYU) to pursue two key aims: 1) identifying and assessing the intersection of cancer predisposition databases with the All of...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $193,144 to The Trustees of Columbia University in the City of New York to support a multidisciplinary postdoctoral training program focused on gastrointestinal (GI) cancers. The 5-year program, running from September 1, 2024 to August 31, 2029, aims to train the next generation of GI cancer researchers across basic science, translational, clinical, epidemiological, and...
This Project Grant award of $145,937 from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) supports the Huntsman Cancer Institute Oncological Data Science (ODSI) Training Program at the University of Utah. The program provides a two-year predoctoral training program that integrates cancer biology, bioinformatics, epidemiology, and data science to prepare young scientists to become experts in leveraging data science techniques to advance cancer research, prevention, diagnosis, and treatment. The program will support six predoctoral candidates per year, selected from the university's existing graduate programs in related fields. Trainees will receive a comprehensive curriculum, opportunities to engage with cancer clinicians, and dedicated mentorship to develop the skills needed to become "data ambassadors and data innovators" in cancer research.